• Corpus ID: 76655383

Amperometric enzyme-based biosensors : refined bioanalytical tools for in vivo biomonitoring

  title={Amperometric enzyme-based biosensors : refined bioanalytical tools for in vivo biomonitoring},
  author={M. Devries and P E Oomen and Cremers Tifh and B. H. C. Westerink},
Diabetes Mellitus is a chronic disease characterized by poor glucose regulation. On a long term, diabetes can lead to severe complications such as nephropathies, neuropathies, blindness and cardiovascular disorders. It is currently a leading cause of death, worldwide. With the number of diabetes patients rapidly increasing, the need for a solutions to improve glucose control became crucial. Despite endless evidence that continuous glucose monitoring (CGM) leads to better diabetes management… 

Figures from this paper



Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises

A critical comparison of existing CGM technologies is presented, highlighting critical issues of device accuracy, foreign body response, calibration, and miniaturization.

Microdialysis-coupled enzymatic microreactor for in vivo glucose monitoring in rats.

A microfluidic device with integrated chaotic mixer and EMR has been successfully combined with subcutaneous microdialysis to continuously monitor glucose in rats, demonstrating the feasibility of improved miniaturization in CGM based on microfluidity.

Biosensors for real-time in vivo measurements.

A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1).

Delays in Minimally Invasive Continuous Glucose Monitoring Devices: A Review of Current Technology

Results demonstrate that the digital filters used by each algorithm do not cause adverse effects to fast physiologic glucose excursions, although nonphysiologic signal characteristics can produce greater delays.

Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring.

A new miniaturized glucose oxidase based needle-type glucose microsensor has been developed for subcutaneous glucose monitoring and exhibits good selectivity against common interferences except for the exogenous drug acetaminophen.